Communiqués RetinalGenix Technologies Inc.

Actions

RTGN

US76133Y1055

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets Autres places de cotation 18:38:36 04/05/2026			Varia. 5j.	Varia. 1 janv.
4,000 ^USD	+25,00%		-.--%	+25,00%

20/05	RetinalGenix Technologies Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI
15/04	RetinalGenix Technologies Inc. publie ses résultats pour l'exercice clos le 31 décembre 2025	CI

Communiqués

14/01	RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study	GL
09/12	RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO	GL
01/10/25	RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases	GL
25/09/25	RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care	GL
30/06/25	RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening	AQ
27/06/25	RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening	GL
16/06/25	RetinalGeniX Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives	AQ
13/06/25	RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives	GL
05/05/25	RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs	GL
05/05/25	RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs	AQ
06/03/25	RetinalGenix Technologies to Participate at the 37th Annual Roth Conference	GL
20/02/25	RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring	GL
14/11/24	RetinalGenix Technologies : Late Filing Notice Form NT 10 Q	PU
22/02/24	RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy	GL
22/02/24	RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy	AQ
26/12/23	RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	GL
21/12/23	RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board	GL
21/12/23	RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board	AQ
04/12/23	RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors	GL
04/12/23	RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors	AQ
01/12/23	RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO	GL
28/11/23	RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board	GL
28/11/23	RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board	AQ
09/11/23	RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs	GL
08/11/23	RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device	GL